CoreWeave, Inc. (CRWV)
NASDAQ: CRWV · Real-Time Price · USD
117.76
-30.99 (-20.83%)
At close: Aug 13, 2025, 4:00 PM
119.10
+1.34 (1.14%)
After-hours: Aug 13, 2025, 7:59 PM EDT
CoreWeave Revenue
CoreWeave had revenue of $1.21B in the quarter ending June 30, 2025, with 542.76% growth. This brings the company's revenue in the last twelve months to $3.53B. In the year 2024, CoreWeave had annual revenue of $1.92B with 736.64% growth.
Revenue (ttm)
$3.53B
Revenue Growth
+736.64%
P/S Ratio
9.87
Revenue / Employee
$4,002,033
Employees
881
Market Cap
56.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.92B | 1.69B | 736.64% |
Dec 31, 2023 | 228.94M | 213.11M | 1,346.26% |
Dec 31, 2022 | 15.83M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCRWV News
- 15 hours ago - CoreWeave's stock is polarizing Wall Street. These are the big post-earnings debates. - Market Watch
- 15 hours ago - CoreWeave's AI Demand Surges But Expansion Spending Cuts Into Profitability - Benzinga
- 16 hours ago - Why post-earnings decline in CoreWeave stock is justified and what comes next - Invezz
- 16 hours ago - CoreWeave Is In A Catch-22: We See 2 Windows To Buy - Seeking Alpha
- 17 hours ago - CoreWeave Stock Drops as Nvidia-Backed Firm's Loss Exceeds Forecasts - Investopedia
- 17 hours ago - CoreWeave stock slumps 14% on wider-than-expected loss ahead of lockup expiration - CNBC
- 18 hours ago - CoreWeave To Double Down, Captures Microsoft And Google's AI Dollars - Benzinga
- 19 hours ago - CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga